SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Dec 18 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pancho Villa who wrote (735)9/28/1997 12:59:00 AM
From: Hong-Lee Yu   of 1359
 
Pancho,

Although the annual sales of redeux may be more than citicoline, IPIC only derives around 6 - 12% royalty from Redeux, but own the right of citicoline entirely. Lehman thinks that the annual sales of citicoline could be 200 - 300 M in year 2000. This implies a market value between 1 B and 2.4 B ( market value between 6 and 8 times the sales) in year 2000.

Just my opinion.

Hong-Lee
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News